docRamachandran Plots
download 
Denúncia Transcrição
Ramachandran Plots
MolProbity Ramachandran analysis 2MPH, all models General case 180 Psi [19] 17 SER [16] 17 SER [7] 17 SER [9] 17 SER [18] 17 SER [4] SER [20] [2] [6] [3] 17 [17] 44 44 44 44 LEU LEU LEU LEU [3] [12] 3434SER SER [1] [10]102 98GLU THR [1] 3 3 ALA ALA [9] [18] 8ARG ARG [2] 8ASN [19] [15] [20] [12] 75 8 THR ARG ARG [10] [14] 87 [1] 157 [4] ARG [5] ARG [6] [15] 888LYS ARG ARG Isoleucine and valine 180 [3] 4103 ALA [8] 100 SER [7] [13] 83 77 98 GLU SER THR THR [17] GLU [18] 93 ASP [7] [13] [19] 84 77 2ALA GLN ALA SER [4] [15] 392 90 LEU [5] 96 LYS [10] GLN [1] 9284GLU [10] [20] 76 83 GLU GLU [20] 96 THR LYS [7] 103 [3] 80 79 SER [15] 104 80LYS LYS LEU [2] [5] [8] [20] 79 91 84 SER ASN GLN 84 90 GLN LEU [3] [10] [12] [18] 104 91 104 102 100 80 ASN LEU LYS LEU GLU SER [2] [6] [20] 75 97 91 THR GLU ASN [10] 90 LEU [16] [16] 87 96 ASN LYS [5] [11] [11]90 75 104 82 THR SER LEU [12] [14] 90 98 LEU THR [20] 80 LYS [1] [15] 92 LEU GLU [2] [9] 100 84 GLN SER [20] 3 ALA [3] 87 ASN [2] [17] 4 104 ALA LEU [10] [19] 75 104 THR 103 THR [10][19] 211 ASNLEU [11] 78 ILE [16] 88 VAL [7] 88 VAL [16] 85 VAL [20] 444ALA 4ALA ALA [10] [6] [14] ALA [4] 4 ALA [17] [6] 81 81VAL VAL [18]85 VAL [9] [4] 8885 VAL VAL [7] 85 VAL Psi [1] 85 88VAL VAL [2] [15] 158 ASN [5] 93 3 ALA [8] ASP [17] 156 LYS 0 0 [3] [9] 106 99 LYS GLU [2] [5] [8] [11] [12] [13] [14] [19] [20] [2] [5] [15] 96 99 93 76 90 76 83 97 93 87 76 LYS ASP LEU GLU ASN GLU [3] [4] [9] [13] 105 89 89 98 105 LYS LYS THR ASP ASP [1] [6] 101 89 LYS GLU [14] [4] 122 76 GLU THR [17] [6] [12] [17] [19] 122 106 122 THR GLU THR [8] [13] [14] [10] [18] 122 122 122 82 ASP SER THR THR THR [6] 105 82 SER [11] [2] [6] 7881 VAL ILE [11] [10]85 [16] 78 VAL ILE [2] [10] [17] 197 197 197ALA ALA ALA [9] [16] [1] 100 76 99 83GLU LYS GLU [2] [10] [12] [6] [18] [20] 106 106 106 99 SER GLU LYS GLU GLU [10] [9] 75 75THR THR [10] 3 ALA [10] 86 LYS [20] 17 SER -180 -180 0 Phi 180 Pre-proline 180 [1] 78 ILE -180 -180 Phi 180 Glycine 180 Psi 0 Psi [14] 107 GLY [3] 107 GLY [8] 107[12] GLY107 GLY [17] [5][18] 107 107107 GLY GLY [20] GLY [4]107 107 GLY [18] 74 GLY 0 0 [15] 74 GLY -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi Psi 0 0 Phi 180 Phi 180 Cis proline 180 [3] 109 PRO 0 [10] 109 PRO [6] 109 PRO [17] 109 PRO [1] [18] 109 PRO [9]109 [13] 109 109 PRO PRO [8] [7] 109 PRO PRO [2] 95 PRO [2] 109 PRO -180 -180 84.6% (3755/4440) of all residues were in favored (98%) regions. 95.7% (4247/4440) of all residues were in allowed (>99.8%) regions. There were 193 outliers (phi, psi): [1] 3 ALA (-175.3, 76.0) [1] 78 ILE (45.1, -171.1) [1] 88 VAL (63.8, 91.0) [1] 89 LYS (-173.7, -41.7) [1] 90 LEU (56.8, 100.4) 180 -180 0 [10] 99 LYS (62.5, -80.8) [10] 102 GLU (60.1, 109.6) [10] 104 LEU (60.4, 93.1) [10] 109 PRO (-49.4, -71.8) [10] 197 ALA (-164.6, -77.5) [1] 92 GLU (62.6, 145.0) [1] 99 LYS (64.5, -79.7) [1] 102 GLU (-176.6, 92.7) [1] 109 PRO (-57.2, -160.6) [1] 157 LYS (-59.9, 94.5) [10] 211 ASN (42.1, 88.8) [11] 76 GLU (-177.5, -39.5) [11] 78 ILE (60.1, 158.7) [11] 81 VAL (-158.7, -44.6) [11] 82 SER (61.7, 103.3) [11] 85 VAL (-167.5, -42.9) [11] 104 LEU (60.3, 103.8) [12] 8 ARG (-49.0, 96.3) [12] 34 SER (-31.9, 152.5) [12] 80 LYS (60.1, 109.3) [12] 83 GLU (-177.9, -39.3) [12] 93 ASP (-177.1, -39.8) [12] 98 THR (60.6, 102.9) [12] 106 GLU (62.5, -81.0) [12] 107 GLY (169.9, 81.0) [12] 122 THR (-164.0, -43.6) [13] 77 SER (61.4, 154.7) [2] 100 SER (62.8, -80.6) [2] 109 PRO (-52.3, -176.1) [2] 197 ALA (-162.8, -77.0) [3] 4 ALA (59.3, 163.6) [3] 34 SER (-33.7, 156.1) [3] 44 LEU (-47.8, 170.3) [13] 83 GLU (-177.6, -39.4) [13] 97 GLU (-177.1, -39.8) [13] 98 THR (60.4, 158.4) [13] 103 THR (60.2, 158.7) [13] 105 ASP (-174.9, -40.4) [13] 109 PRO (-56.7, -162.6) [3] 79 SER (62.0, 116.5) [3] 87 ASN (60.9, 97.7) [3] 89 LYS (-174.3, -40.5) [3] 91 ASN (59.9, 109.4) [3] 104 LEU (59.6, 109.3) [3] 106 GLU (-179.9, -38.5) [13] 122 THR (-164.4, -44.1) [14] 4 ALA (166.0, 85.6) [14] 8 ARG (-48.9, 95.3) [14] 76 GLU (-169.0, -42.2) [14] 90 LEU (60.3, 102.5) [14] 97 GLU (-177.7, -39.3) [3] 107 GLY (158.8, 92.2) [3] 109 PRO (-51.5, 179.1) [4] 3 ALA (61.9, 152.2) [4] 4 ALA (168.3, 76.5) [4] 8 ARG (-49.3, 93.6) [14] 107 GLY (59.0, 91.7) [14] 122 THR (-162.1, -44.0) [15] 8 ARG (-52.3, 89.4) [15] 74 GLY (179.9, -85.0) [15] 75 THR (-57.1, 96.2) [4] 17 SER (-53.4, 173.7) [4] 88 VAL (63.5, 109.1) [4] 98 THR (-175.0, -40.4) [4] 107 GLY (164.4, 62.3) [4] 122 THR (-167.7, -42.7) [5] 3 ALA (-174.3, 40.6) [15] 76 GLU (-177.0, -39.5) [15] 80 LYS (61.3, 113.8) [15] 90 LEU (61.8, 152.0) [15] 92 GLU (60.4, 100.7) [15] 104 LEU (61.3, 113.2) [15] 158 ASN (-176.5, 46.2) [5] 8 ARG (-50.8, 92.7) [5] 75 THR (56.3, 103.8) [5] 76 GLU (-176.9, -39.7) [5] 84 GLN (60.5, 110.4) [5] 91 ASN (60.8, 111.6) [5] 93 ASP (-177.6, -39.5) [16] 17 SER (-54.6, 178.6) [16] 78 ILE (-157.5, -44.4) [16] 83 GLU (63.8, -80.0) [16] 85 VAL (64.0, 133.1) [16] 87 ASN (56.7, 104.3) [16] 88 VAL (63.9, 151.1) [5] 96 LYS (62.0, 151.3) [5] 107 GLY (136.4, 70.0) [6] 4 ALA (163.2, 86.5) [6] 8 ARG (-52.6, 89.9) [6] 44 LEU (-48.0, 170.5) [16] 96 LYS (60.7, 104.1) [17] 44 LEU (-47.1, 170.8) [17] 77 SER (60.4, 158.0) [17] 81 VAL (62.1, 116.6) [17] 92 GLU (60.6, 157.7) [6] 78 ILE (-159.5, -42.6) [6] 81 VAL (63.9, 116.6) [6] 82 SER (-160.9, -48.7) [6] 97 GLU (59.3, 108.0) [6] 101 GLU (-172.2, -41.4) [6] 106 GLU (63.8, -80.2) [17] 104 LEU (59.9, 96.1) [17] 106 GLU (-165.1, -43.4) [17] 107 GLY (133.6, 69.5) [17] 109 PRO (-57.4, -159.5) [17] 122 THR (-163.6, -43.6) [17] 156 LYS (-166.9, 32.0) [6] 109 PRO (-57.8, -158.3) [6] 122 THR (-164.3, -43.4) [7] 17 SER (-50.8, 177.3) [7] 83 GLU (60.8, 158.7) [7] 84 GLN (61.2, 154.8) [7] 85 VAL (-165.9, 102.9) [17] 197 ALA (-162.7, -77.5) [18] 8 ARG (-49.3, 99.4) [18] 17 SER (-49.4, 176.0) [18] 74 GLY (174.0, 38.7) [18] 85 VAL (63.5, 111.7) [18] 90 LEU (60.5, 110.8) [7] 88 VAL (63.8, 141.1) [7] 103 THR (63.6, 126.5) [7] 109 PRO (-63.9, -166.7) [8] 80 LYS (60.7, 111.0) [8] 93 ASP (-177.4, 38.0) -180 Phi [10] 86 LYS (-59.3, -172.2) [10] 87 ASN (-61.2, 95.3) [10] 90 LEU (58.6, 106.9) [10] 98 THR (-175.7, 87.2) [2] 4 ALA (59.3, 96.8) [2] 8 ARG (-48.6, 98.6) [2] 44 LEU (-48.8, 170.3) [2] 75 THR (57.9, 107.4) [2] 76 GLU (-176.0, -40.0) [2] 78 ILE (-159.0, -42.6) [2] 79 SER (60.6, 111.1) [2] 84 GLN (59.3, 99.0) [2] 85 VAL (59.3, 88.4) [2] 89 LYS (-175.7, -40.1) [2] 95 PRO (-53.5, -172.8) [2] 96 LYS (-177.3, -39.6) 0 [18] 93 ASP (61.8, 155.5) [18] 100 SER (60.6, 109.5) [18] 104 LEU (60.0, 109.5) [18] 106 GLU (63.7, -80.3) [18] 107 GLY (147.4, 66.8) [8] 99 LYS (-177.7, -39.4) [8] 100 SER (60.7, 159.2) [8] 105 ASP (-164.3, -44.2) [8] 107 GLY (136.6, 77.7) [8] 109 PRO (-64.3, -166.2) [9] 3 ALA (-175.6, 73.1) [18] 109 PRO (-57.4, -160.9) [18] 122 THR (-160.6, -44.8) [19] 2 ALA (61.1, 155.0) [19] 8 ARG (-49.9, 97.4) [19] 17 SER (-52.0, 179.5) [19] 75 THR (43.0, 92.8) [9] 17 SER (-55.0, 176.6) [9] 75 THR (52.3, -87.5) [9] 76 GLU (63.9, -80.0) [9] 85 VAL (59.9, 109.5) [9] 99 LYS (-178.9, -39.0) [19] 90 LEU (-177.6, -39.5) [19] 103 THR (60.3, 92.4) [19] 122 THR (-163.1, -43.5) [20] 3 ALA (60.0, 98.7) [20] 4 ALA (167.1, 89.6) [9] 100 SER (59.9, 99.8) [9] 105 ASP (-174.9, -40.6) [9] 109 PRO (-56.9, -162.2) [10] 3 ALA (-60.8, -168.1) [10] 4 ALA (161.7, 87.2) [10] 75 THR (51.6, -87.8) [20] 8 ARG (-49.1, 96.0) [20] 17 SER (-56.4, -179.7) [20] 44 LEU (-50.8, 170.5) [20] 80 LYS (61.0, 101.3) [20] 83 GLU (63.6, 138.7) [20] 84 GLN (60.7, 111.5) [10] 76 GLU (63.4, 143.2) [10] 78 ILE (-157.5, -45.0) [10] 82 SER (-161.6, -44.7) [10] 84 GLN (62.8, 147.7) [20] 87 ASN (-177.5, -39.6) [20] 91 ASN (60.4, 107.9) [20] 96 LYS (63.2, 128.1) [20] 106 GLU (63.7, -80.2) [20] 107 GLY (148.3, 66.9) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 1 General case 180 Isoleucine and valine 180 [1] 92 GLU Psi [1] 102 GLU [1] [1] 157 LYS [1] 90 LEU Psi [1] 88 VAL 3 ALA 0 0 [1] 89 LYS [1] 99 LYS -180 [1] 78 ILE -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 0 [1] 109 PRO -180 -180 -180 0 Phi 180 -180 0 82.9% (184/222) of all residues were in favored (98%) regions. 95.5% (212/222) of all residues were in allowed (>99.8%) regions. There [1] [1] [1] [1] [1] [1] [1] [1] [1] [1] were 10 outliers (phi, psi): 3 ALA (-175.3, 76.0) 78 ILE (45.1, -171.1) 88 VAL (63.8, 91.0) 89 LYS (-173.7, -41.7) 90 LEU (56.8, 100.4) 92 GLU (62.6, 145.0) 99 LYS (64.5, -79.7) 102 GLU (-176.6, 92.7) 109 PRO (-57.2, -160.6) 157 LYS (-59.9, 94.5) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 2 General case 180 [2] Psi 8 ARG Isoleucine and valine 180 [2] 44 LEU [2] 75 79 THR SER [2] [2] GLN [2] 84 4 ALA Psi 0 [2] 85 VAL 0 [2] [2] 96 76 GLU 89 LYS LYS [2] 78 ILE [2] 197 ALA [2] 100 SER -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 [2] 95 PRO [2] 109 PRO -180 -180 0 Cis proline 180 Psi 0 -180 Phi 180 -180 0 84.7% (188/222) of all residues were in favored (98%) regions. 93.2% (207/222) of all residues were in allowed (>99.8%) regions. There [2] [2] [2] [2] [2] [2] [2] [2] [2] [2] [2] [2] [2] [2] [2] were 15 outliers (phi, psi): 4 ALA (59.3, 96.8) 8 ARG (-48.6, 98.6) 44 LEU (-48.8, 170.3) 75 THR (57.9, 107.4) 76 GLU (-176.0, -40.0) 78 ILE (-159.0, -42.6) 79 SER (60.6, 111.1) 84 GLN (59.3, 99.0) 85 VAL (59.3, 88.4) 89 LYS (-175.7, -40.1) 95 PRO (-53.5, -172.8) 96 LYS (-177.3, -39.6) 100 SER (62.8, -80.6) 109 PRO (-52.3, -176.1) 197 ALA (-162.8, -77.0) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 3 General case 180 [3] 44 LEU [3] 34 SER [3] 4 ALA [3] 79 SER [3] 104 91 ASN LEU [3] 87 ASN Psi Isoleucine and valine 180 Psi 0 0 [3] [3] 106 89 GLU LYS -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Glycine 180 Psi 0 [3] 107 GLY -180 -180 0 Phi 180 Trans proline 180 -180 Psi Psi 0 0 -180 Phi 180 Phi 180 Cis proline 180 [3] 109 PRO 0 -180 -180 0 Phi 180 -180 0 84.7% (188/222) of all residues were in favored (98%) regions. 95.0% (211/222) of all residues were in allowed (>99.8%) regions. There were 11 outliers (phi, psi): [3] 4 ALA (59.3, 163.6) [3] 34 SER (-33.7, 156.1) [3] 44 LEU (-47.8, 170.3) [3] [3] [3] [3] [3] [3] [3] 79 SER (62.0, 116.5) 87 ASN (60.9, 97.7) 89 LYS (-174.3, -40.5) 91 ASN (59.9, 109.4) 104 LEU (59.6, 109.3) 106 GLU (-179.9, -38.5) 107 GLY (158.8, 92.2) [3] 109 PRO (-51.5, 179.1) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 4 General case 180 [4] Isoleucine and valine 180 [4] 17 SER 3 ALA [4] 88 VAL Psi [4] Psi 8 ARG [4] 0 4 ALA 0 [4] THR [4] 98 122 THR -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Phi 180 Glycine 180 Psi 0 Psi [4] 107 GLY 0 0 -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Cis proline 180 Psi 0 -180 -180 0 Phi 180 -180 0 83.3% (185/222) of all residues were in favored (98%) regions. 96.4% (214/222) of all residues were in allowed (>99.8%) regions. There [4] [4] [4] [4] [4] [4] [4] [4] were 8 outliers (phi, psi): 3 ALA (61.9, 152.2) 4 ALA (168.3, 76.5) 8 ARG (-49.3, 93.6) 17 SER (-53.4, 173.7) 88 VAL (63.5, 109.1) 98 THR (-175.0, -40.4) 107 GLY (164.4, 62.3) 122 THR (-167.7, -42.7) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 5 General case 180 Isoleucine and valine 180 [5] 96 LYS [5] 84 91 GLN ASN [5] 75 THR Psi [5] [5] Psi 8 ARG 3 ALA 0 0 [5] [5] 93 76 ASP GLU -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Phi 180 Glycine 180 Psi 0 Psi [5] 107 GLY 0 0 -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Cis proline 180 Psi 0 -180 -180 0 Phi 180 -180 0 85.1% (189/222) of all residues were in favored (98%) regions. 95.9% (213/222) of all residues were in allowed (>99.8%) regions. There [5] [5] [5] [5] [5] [5] [5] [5] [5] were 9 outliers (phi, psi): 3 ALA (-174.3, 40.6) 8 ARG (-50.8, 92.7) 75 THR (56.3, 103.8) 76 GLU (-176.9, -39.7) 84 GLN (60.5, 110.4) 91 ASN (60.8, 111.6) 93 ASP (-177.6, -39.5) 96 LYS (62.0, 151.3) 107 GLY (136.4, 70.0) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 6 General case 180 Isoleucine and valine 180 [6] 44 LEU [6] 81 VAL [6] 97 GLU Psi [6] 8 ARG [6] 0 4 ALA Psi 0 [6][6]101 GLU THR [6] 122 82 SER [6] 78 ILE [6] 106 GLU -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 0 [6] 109 PRO -180 -180 -180 0 Phi 180 -180 0 82.9% (184/222) of all residues were in favored (98%) regions. 95.0% (211/222) of all residues were in allowed (>99.8%) regions. There were 11 outliers (phi, psi): [6] 4 ALA (163.2, 86.5) [6] 8 ARG (-52.6, 89.9) [6] 44 LEU (-48.0, 170.5) [6] [6] [6] [6] [6] [6] [6] 78 ILE (-159.5, -42.6) 81 VAL (63.9, 116.6) 82 SER (-160.9, -48.7) 97 GLU (59.3, 108.0) 101 GLU (-172.2, -41.4) 106 GLU (63.8, -80.2) 109 PRO (-57.8, -158.3) [6] 122 THR (-164.3, -43.4) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 7 General case 180 Isoleucine and valine 180 [7] 17 SER [7] [7] 83 84 GLU GLN [7] 88 VAL [7] 103 THR Psi Psi 0 0 -180 [7] 85 VAL -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 0 [7] 109 PRO -180 -180 -180 0 Phi 180 -180 0 85.6% (190/222) of all residues were in favored (98%) regions. 96.8% (215/222) of all residues were in allowed (>99.8%) regions. There [7] [7] [7] [7] [7] [7] [7] were 7 outliers (phi, psi): 17 SER (-50.8, 177.3) 83 GLU (60.8, 158.7) 84 GLN (61.2, 154.8) 85 VAL (-165.9, 102.9) 88 VAL (63.8, 141.1) 103 THR (63.6, 126.5) 109 PRO (-63.9, -166.7) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 8 General case 180 Isoleucine and valine 180 [8] 100 SER [8] 80 LYS Psi Psi [8] 93 ASP 0 0 [8] [8]99 105 LYSASP -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Phi 180 Glycine 180 Psi 0 Psi [8] 107 GLY 0 0 -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 Phi 180 Phi 180 Cis proline 180 Psi 0 [8] 109 PRO -180 -180 -180 0 Phi 180 -180 0 86.0% (191/222) of all residues were in favored (98%) regions. 96.8% (215/222) of all residues were in allowed (>99.8%) regions. There [8] [8] [8] [8] [8] [8] [8] were 7 outliers (phi, psi): 80 LYS (60.7, 111.0) 93 ASP (-177.4, 38.0) 99 LYS (-177.7, -39.4) 100 SER (60.7, 159.2) 105 ASP (-164.3, -44.2) 107 GLY (136.6, 77.7) 109 PRO (-64.3, -166.2) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 9 General case 180 Isoleucine and valine 180 [9] 17 SER [9] 85 VAL [9] 100 SER Psi [9] Psi 3 ALA 0 0 [9] [9] 99 105LYS ASP [9] 76 GLU [9] 75 THR -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 0 [9] 109 PRO -180 -180 -180 0 Phi 180 -180 0 83.3% (185/222) of all residues were in favored (98%) regions. 95.9% (213/222) of all residues were in allowed (>99.8%) regions. There [9] [9] [9] [9] [9] [9] [9] [9] [9] were 9 outliers (phi, psi): 3 ALA (-175.6, 73.1) 17 SER (-55.0, 176.6) 75 THR (52.3, -87.5) 76 GLU (63.9, -80.0) 85 VAL (59.9, 109.5) 99 LYS (-178.9, -39.0) 100 SER (59.9, 99.8) 105 ASP (-174.9, -40.6) 109 PRO (-56.9, -162.2) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 10 General case 180 Isoleucine and valine 180 [10] [10] 84 76 GLN GLU Psi [10] 98 THR [10] 87 ASN [10] 102 GLU [10] 90 LEU [10][10] 211 104 ASNLEU [10] 0 4 ALA Psi 0 [10] 82 SER [10] 78 ILE [10] 197 ALA [10] 99 LYS [10] 75 THR [10] 3 ALA [10] 86 LYS -180 -180 0 -180 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 0 [10] 109 PRO -180 -180 -180 0 Phi 180 -180 0 82.9% (184/222) of all residues were in favored (98%) regions. 92.3% (205/222) of all residues were in allowed (>99.8%) regions. There were 17 outliers (phi, psi): [10] 3 ALA (-60.8, -168.1) [10] [10] 4 ALA (161.7, 87.2) 75 THR (51.6, -87.8) [10] 76 GLU (63.4, 143.2) [10] 78 ILE (-157.5, -45.0) [10] 82 SER (-161.6, -44.7) [10] 84 GLN (62.8, 147.7) [10] 86 LYS (-59.3, -172.2) [10] 87 ASN (-61.2, 95.3) [10] 90 LEU (58.6, 106.9) [10] 98 THR (-175.7, 87.2) [10] 99 LYS (62.5, -80.8) [10] 102 GLU (60.1, 109.6) [10] 104 LEU (60.4, 93.1) [10] 109 PRO (-49.4, -71.8) [10] 197 ALA (-164.6, -77.5) [10] 211 ASN (42.1, 88.8) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 11 General case 180 Isoleucine and valine 180 [11] 78 ILE [11] [11] 104 82 SER LEU Psi Psi 0 0 [11] 76 GLU [11] VAL [11] 8581 VAL -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 -180 0 -180 -180 0 Phi 180 -180 0 85.6% (190/222) of all residues were in favored (98%) regions. 97.3% (216/222) of all residues were in allowed (>99.8%) regions. There were 6 outliers (phi, psi): [11] 76 GLU (-177.5, -39.5) [11] 78 ILE (60.1, 158.7) [11] 81 VAL (-158.7, -44.6) [11] 82 SER (61.7, 103.3) [11] 85 VAL (-167.5, -42.9) [11] 104 LEU (60.3, 103.8) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 12 General case 180 Isoleucine and valine 180 [12] 34 SER [12] Psi 8 ARG [12] 80 LYS [12] 98 THR Psi 0 0 [12][12] 83 93 122 GLU ASPTHR [12] 106 GLU -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Glycine 180 Psi 0 [12] 107 GLY -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Cis proline 180 Psi 0 -180 -180 0 Phi 180 -180 0 85.1% (189/222) of all residues were in favored (98%) regions. 95.9% (213/222) of all residues were in allowed (>99.8%) regions. There were 9 outliers (phi, psi): [12] 8 ARG (-49.0, 96.3) [12] 34 SER (-31.9, 152.5) [12] 80 LYS (60.1, 109.3) [12] 83 GLU (-177.9, -39.3) [12] 93 ASP (-177.1, -39.8) [12] 98 THR (60.6, 102.9) [12] 106 GLU (62.5, -81.0) [12] 107 GLY (169.9, 81.0) [12] 122 THR (-164.0, -43.6) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 13 General case 180 Isoleucine and valine 180 [13] 98 THR THR [13] 103 77 SER Psi Psi 0 0 [13] 83 GLU [13] 105 ASP [13]97 122 THR -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 0 [13] 109 PRO -180 -180 -180 0 Phi 180 -180 0 84.2% (187/222) of all residues were in favored (98%) regions. 96.4% (214/222) of all residues were in allowed (>99.8%) regions. There were 8 outliers (phi, psi): [13] 77 SER (61.4, 154.7) [13] 83 GLU (-177.6, -39.4) [13] 97 GLU (-177.1, -39.8) [13] 98 THR (60.4, 158.4) [13] 103 THR (60.2, 158.7) [13] 105 ASP (-174.9, -40.4) [13] 109 PRO (-56.7, -162.6) [13] 122 THR (-164.4, -44.1) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 14 General case 180 Psi [14] 8 ARG Isoleucine and valine 180 [14] 90 LEU [14] 0 4 ALA Psi 0 [14] 9776 GLU [14] GLU [14] 122 THR -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Glycine 180 Psi 0 [14] 107 GLY -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Cis proline 180 Psi 0 -180 -180 0 Phi 180 -180 0 87.4% (194/222) of all residues were in favored (98%) regions. 96.8% (215/222) of all residues were in allowed (>99.8%) regions. There were 7 outliers (phi, psi): [14] 4 ALA (166.0, 85.6) [14] 8 ARG (-48.9, 95.3) [14] 76 GLU (-169.0, -42.2) [14] [14] [14] [14] 90 LEU (60.3, 102.5) 97 GLU (-177.7, -39.3) 107 GLY (59.0, 91.7) 122 THR (-162.1, -44.0) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 15 General case 180 Isoleucine and valine 180 [15] 90 LEU [15] 75 THR [15] 8 ARG Psi [15] 104 80 LYS LEU [15] 92 GLU Psi [15] 158 ASN 0 0 [15] 76 GLU -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 Phi 180 Glycine 180 Psi 0 [15] 74 GLY -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Cis proline 180 Psi 0 -180 -180 0 Phi 180 -180 0 85.1% (189/222) of all residues were in favored (98%) regions. 95.9% (213/222) of all residues were in allowed (>99.8%) regions. There were 9 outliers (phi, psi): [15] 8 ARG (-52.3, 89.4) [15] 74 GLY (179.9, -85.0) [15] 75 THR (-57.1, 96.2) [15] 76 GLU (-177.0, -39.5) [15] 80 LYS (61.3, 113.8) [15] 90 LEU (61.8, 152.0) [15] 92 GLU (60.4, 100.7) [15] 104 LEU (61.3, 113.2) [15] 158 ASN (-176.5, 46.2) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 16 General case 180 Isoleucine and valine 180 [16] 17 SER [16] 88 VAL [16] 85 VAL [16] [16] 87 96 ASN LYS Psi Psi 0 0 [16] 78 ILE [16] 83 GLU -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 -180 0 -180 -180 0 Phi 180 -180 0 84.7% (188/222) of all residues were in favored (98%) regions. 96.8% (215/222) of all residues were in allowed (>99.8%) regions. There were 7 outliers (phi, psi): [16] 17 SER (-54.6, 178.6) [16] 78 ILE (-157.5, -44.4) [16] 83 GLU (63.8, -80.0) [16] [16] [16] [16] 85 VAL (64.0, 133.1) 87 ASN (56.7, 104.3) 88 VAL (63.9, 151.1) 96 LYS (60.7, 104.1) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 17 General case 180 Isoleucine and valine 180 [17] 44 LEU 77 GLU SER [17] 92 [17] 81 VAL [17] 104 LEU Psi Psi [17] 156 LYS 0 0 [17] [17] 106 122 GLU THR [17] 197 ALA -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Phi 180 Glycine 180 Psi 0 Psi [17] 107 GLY 0 0 -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 Phi 180 Phi 180 Cis proline 180 Psi 0 [17] 109 PRO -180 -180 -180 0 Phi 180 -180 0 85.1% (189/222) of all residues were in favored (98%) regions. 95.0% (211/222) of all residues were in allowed (>99.8%) regions. There were 11 outliers (phi, psi): [17] 44 LEU (-47.1, 170.8) [17] 77 SER (60.4, 158.0) [17] 81 VAL (62.1, 116.6) [17] [17] [17] [17] [17] [17] [17] 92 GLU (60.6, 157.7) 104 LEU (59.9, 96.1) 106 GLU (-165.1, -43.4) 107 GLY (133.6, 69.5) 109 PRO (-57.4, -159.5) 122 THR (-163.6, -43.6) 156 LYS (-166.9, 32.0) [17] 197 ALA (-162.7, -77.5) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 18 General case 180 Isoleucine and valine 180 [18] 17 SER [18] 93 ASP [18] 85 VAL 90 LEU [18] 104 100 LEU SER [18] Psi 8 ARG Psi 0 0 [18] 122 THR [18] 106 GLU -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Phi 180 Glycine 180 Psi 0 Psi [18] 107 GLY [18] 74 GLY 0 0 -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 Phi 180 Phi 180 Cis proline 180 Psi 0 [18] 109 PRO -180 -180 -180 0 Phi 180 -180 0 85.6% (190/222) of all residues were in favored (98%) regions. 94.6% (210/222) of all residues were in allowed (>99.8%) regions. There were 12 outliers (phi, psi): [18] 8 ARG (-49.3, 99.4) [18] 17 SER (-49.4, 176.0) [18] 74 GLY (174.0, 38.7) [18] 85 VAL (63.5, 111.7) [18] 90 LEU (60.5, 110.8) [18] 93 ASP (61.8, 155.5) [18] 100 SER (60.6, 109.5) [18] 104 LEU (60.0, 109.5) [18] 106 GLU (63.7, -80.3) [18] 107 GLY (147.4, 66.8) [18] 109 PRO (-57.4, -160.9) [18] 122 THR (-160.6, -44.8) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 19 General case 180 [19] [19] Psi 8 ARG Isoleucine and valine 180 [19] 17 SER 2 ALA Psi [19][19] 75 THR 103 THR 0 0 [19][19] 90 122 LEUTHR -180 -180 -180 0 Phi 180 Pre-proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Phi 180 Glycine 180 Psi 0 -180 -180 0 Phi 180 Trans proline 180 -180 Cis proline 180 Psi Psi 0 0 -180 0 -180 -180 0 Phi 180 -180 0 83.8% (186/222) of all residues were in favored (98%) regions. 96.8% (215/222) of all residues were in allowed (>99.8%) regions. There were 7 outliers (phi, psi): [19] 2 ALA (61.1, 155.0) [19] 8 ARG (-49.9, 97.4) [19] 17 SER (-52.0, 179.5) [19] [19] [19] [19] 75 THR (43.0, 92.8) 90 LEU (-177.6, -39.5) 103 THR (60.3, 92.4) 122 THR (-163.1, -43.5) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003) MolProbity Ramachandran analysis 2MPH, model 20 General case 180 Isoleucine and valine 180 [20] 44 LEU [20] 83 GLU [20] 96 LYS [20] Psi 8 ARG [20] 84 [20] 91 GLN ASN [20] 80 LYS [20] 3 ALA [20] 0 4 ALA Psi 0 [20] 87 ASN [20] 106 GLU -180 -180 [20] 17 SER -180 0 Phi 180 Pre-proline 180 -180 Phi 180 Glycine 180 Psi 0 Psi [20] 107 GLY 0 0 -180 -180 -180 0 Phi 180 Trans proline 180 -180 Psi 0 0 -180 Phi 180 Phi 180 Cis proline 180 Psi 0 -180 -180 0 Phi 180 -180 0 83.3% (185/222) of all residues were in favored (98%) regions. 94.1% (209/222) of all residues were in allowed (>99.8%) regions. There were 13 outliers (phi, psi): [20] 3 ALA (60.0, 98.7) [20] 4 ALA (167.1, 89.6) [20] 8 ARG (-49.1, 96.0) [20] 17 SER (-56.4, -179.7) [20] 44 LEU (-50.8, 170.5) [20] 80 LYS (61.0, 101.3) [20] 83 GLU (63.6, 138.7) [20] 84 GLN (60.7, 111.5) [20] 87 ASN (-177.5, -39.6) [20] 91 ASN (60.4, 107.9) [20] 96 LYS (63.2, 128.1) [20] 106 GLU (63.7, -80.2) [20] 107 GLY (148.3, 66.9) http://kinemage.biochem.duke.edu Lovell, Davis, et al. Proteins 50:437 (2003)
Documentos relacionados
MolProbity Ramachandran analysis
BG 111 PRO (-56.5, -173.4)
BG 112 VAL (-142.4, -79.5)
BG 117 PRO (-52.1, -101.7)
BG 125 PRO (-53.1, -74.1)
BG 137 LYS (-57.3, -74.8)
BG 151 ARG (-166.0, -72.7)
BG 152 ARG (65.4, 120.6)
BG 155 PRO (...
Ramachandran Plots
B 6 ALA (53.1, -88.5)
B 12 GLU (-66.3, -157.7)
B 13 ARG (38.0, -152.0)
B 19 ILE (-53.9, -79.5)
B 20 LYS (-28.0, -42.9)
B 37 LYS (-47.4, 90.3)
B 61 LEU (-59.1, -78.1)
B 71 GLN (-58.2, -86.0)
B 72 AS...
MolProbity Ramachandran analysis
Q 274 ILE (-22.8, -54.8)
R 2 GLU (-25.5, -50.1)
R 233 SER (47.8, 90.0)
R 242 LEU (-65.2, -171.2)
R 246 GLN (-18.7, 73.5)
R 253 GLU (-40.7, -26.2)
R 274 ILE (-23.0, -54.6)
S 2 GLU (-25.5, -50.3)
S 2...
MolProbity Ramachandran analysis
90.4% (3753/4152) of all residues were in allowed (>99.8%) regions.
MolProbity Ramachandran analysis
3 ALA (87.5, -98.2)
4 ALA (171.2, 16.2)
6 GLY (-174.8, -58.2)
7 ASP (9.6, -102.1)
8 HIS (49.8, -18.1)
39 SER (-61.4, -124.3)
40 GLY (65.7, 129.7)
49 PRO (-59.4, 53.6)
8 ILE (78.9, 10.3)
10 ASN (88....
MolProbity Ramachandran analysis
464 SER (-177.1, -0.7)
466 GLY (-10.5, -111.6)
468 PRO (-73.4, -147.7)
469 PHE (-54.0, 79.5)
24 LYS (-45.4, -14.8)
35 GLY (45.2, 7.1)
40 PRO (-84.6, -116.9)
MolProbity Ramachandran analysis
205 THR (154.1, 65.9)
210 VAL (160.1, -177.3)
211 ALA (-137.1, -164.6)
212 PRO (-112.7, -107.1)
213 THR (118.1, -175.2)
215 CYS (88.8, 139.1)
2 SER (80.8, -78.4)
3 ALA (161.4, -103.5)
4 LEU (161.6,...
Pre-proline
BA1491
SER
AA1596
2112ASP
ALA
B 1302 ALA
Pre-proline
MolProbity Ramachandran analysis
O 83 LYS (-54.6, 176.2)
O 116 SER (-55.5, 0.8)
O 143 ALA (48.7, 178.8)
P 6 PRO (-83.8, -43.3)
P 18 PRO (-21.2, -51.1)
P 23 THR (-28.0, 146.8)
